Lung Squamous Cell Carcinoma Tumors Reveal Therapeutic Alterations

A new study, reported in Oncotarget, found that unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients.